Regarding the sum of all currently available biochemical data for sGC and PDE-5, we suggest a model that shows the mechanism how PDE-5 inhibitors may lower portal pressure in cirrhotic portal hypertension (Figure 1B,C). Here, PDE5A is linked to liver disorder.